Skip to content
Certara Drug Interaction Database (DIDB®)
  • Licensing
    • Does my organization have a DIDB® license?
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
June 14, 2022 |  News

Data Curation and Entry in DIDB – May Summary

In May, we added 74 citations in DIDB, including 29 in vitro (with 15 articles published in May 2022) and 45 in vivo articles (with 32 articles published in May 2022).

One recently approved NDA was also added: Ganaxolone (ZTALMY)

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.

Post navigation

New features! Drug Characteristics now integrated in queries
Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Follow us on Linked

Recent News

  • Understanding Postmarketing Requirements and Commitments for CYP3A-mediated Drug-drug Interactions: An Analysis of FDA-approved Drugs from 2015 to 2024
  • An Evidence-based Approach for Managing DDI risk for Patients in Clinical Trials
  • Data Curation and Entry in DIDB – July 2026 Summary
  • Upcoming DIDB Webinar Series: Transforming Drug Interaction Evaluation Workflows
  • DIDB DDI Calculator: Tutorial Video

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications
  • Blog
  • Contact
  • Privacy
Copyright © 2026 Certara, USA. All Rights Reserved.